ULTRAGENYX PHARMACEUTICAL INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $1.53B
Liabilities Breakdown FY2025
Total Liabilities: $1.61B
Asset Breakdown
Total Assets: $1.53B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $421.0M | 27.5% |
| Accounts Receivable | $158.0M | 10.3% |
| Inventory | $52.0M | 3.4% |
| Property, Plant & Equipment | $244.0M | 15.9% |
| Goodwill | $44.0M | 2.9% |
| Intangible Assets | $176.0M | 11.5% |
| Other Assets | $437.0M | 28.5% |
Liabilities Breakdown
Total Liabilities: $1.61B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $31.0M | 1.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.57B | 98.1% |